Cronos Group Stock Fundamentals
| CRON Stock | USD 1.97 0.01 0.51% |
Cronos Group fundamentals help investors to digest information that contributes to Cronos' financial success or failures. It also enables traders to predict the movement of Cronos Stock. The fundamental analysis module provides a way to measure Cronos' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cronos stock.
At this time, Cronos' Minority Interest is very stable compared to the past year. As of the 30th of December 2024, Non Operating Income Net Other is likely to grow to about 235.9 M, while Other Operating Expenses is likely to drop about 105.3 M. Cronos | Select Account or Indicator |
Cronos Group Company Operating Margin Analysis
Cronos' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cronos Operating Margin | (0.54) % |
Most of Cronos' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cronos Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Cronos Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Cronos Group has an Operating Margin of -0.5408%. This is 98.46% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is 90.19% lower than that of the firm.
Cronos Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cronos's current stock value. Our valuation model uses many indicators to compare Cronos value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cronos competition to find correlations between indicators driving Cronos's intrinsic value. More Info.Cronos Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . At this time, Cronos' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cronos' earnings, one of the primary drivers of an investment's value.Cronos Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cronos' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cronos could also be used in its relative valuation, which is a method of valuing Cronos by comparing valuation metrics of similar companies.Cronos is currently under evaluation in operating margin category among its peers.
Cronos Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cronos from analyzing Cronos' financial statements. These drivers represent accounts that assess Cronos' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cronos' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.4B | 2.4B | 1.5B | 939.9M | 795.6M | 946.8M | |
| Enterprise Value | 2.2B | 1.3B | 578.5M | 179.2M | 128.8M | 122.4M |
Cronos Fundamentals
| Return On Equity | -0.0529 | ||||
| Return On Asset | -0.0373 | ||||
| Profit Margin | (0.56) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | (106.81 M) | ||||
| Shares Outstanding | 382.3 M | ||||
| Shares Owned By Insiders | 46.40 % | ||||
| Shares Owned By Institutions | 15.61 % | ||||
| Number Of Shares Shorted | 3.68 M | ||||
| Price To Earning | 36.41 X | ||||
| Price To Book | 0.70 X | ||||
| Price To Sales | 7.44 X | ||||
| Revenue | 87.24 M | ||||
| Gross Profit | 11.97 M | ||||
| EBITDA | (72.15 M) | ||||
| Net Income | (74.55 M) | ||||
| Cash And Equivalents | 944.89 M | ||||
| Cash Per Share | 2.50 X | ||||
| Total Debt | 2.55 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 26.18 X | ||||
| Book Value Per Share | 2.88 X | ||||
| Cash Flow From Operations | (42.84 M) | ||||
| Short Ratio | 5.07 X | ||||
| Earnings Per Share | (0.12) X | ||||
| Target Price | 1.96 | ||||
| Number Of Employees | 356 | ||||
| Beta | 1.01 | ||||
| Market Capitalization | 756.94 M | ||||
| Total Asset | 1.14 B | ||||
| Retained Earnings | 416.72 M | ||||
| Working Capital | 891.91 M | ||||
| Current Asset | 15.37 M | ||||
| Current Liabilities | 10.59 M | ||||
| Net Asset | 1.14 B |
About Cronos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cronos Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cronos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cronos Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 73.6 K | 69.9 K | |
| Total Revenue | 87.2 M | 91.6 M | |
| Cost Of Revenue | 75.3 M | 40.5 M | |
| Stock Based Compensation To Revenue | 0.10 | 0.10 | |
| Sales General And Administrative To Revenue | 0.67 | 0.63 | |
| Research And Ddevelopement To Revenue | 0.07 | 0.06 | |
| Capex To Revenue | 0.04 | 0.04 | |
| Revenue Per Share | 0.23 | 0.24 | |
| Ebit Per Revenue | (0.97) | (1.02) |
Pair Trading with Cronos
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cronos position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cronos will appreciate offsetting losses from the drop in the long position's value.Moving together with Cronos Stock
Moving against Cronos Stock
| 0.74 | VCEL | Vericel Corp Ord | PairCorr |
| 0.73 | DRTS | Alpha Tau Medical | PairCorr |
| 0.71 | VCYT | Veracyte | PairCorr |
| 0.69 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.68 | DYAI | Dyadic International | PairCorr |
The ability to find closely correlated positions to Cronos could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cronos when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cronos - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cronos Group to buy it.
The correlation of Cronos is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cronos moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cronos Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cronos can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Cronos Piotroski F Score and Cronos Altman Z Score analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cronos. If investors know Cronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cronos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.144 | Earnings Share (0.12) | Revenue Per Share 0.267 | Quarterly Revenue Growth 0.46 | Return On Assets (0.04) |
The market value of Cronos Group is measured differently than its book value, which is the value of Cronos that is recorded on the company's balance sheet. Investors also form their own opinion of Cronos' value that differs from its market value or its book value, called intrinsic value, which is Cronos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cronos' market value can be influenced by many factors that don't directly affect Cronos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cronos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cronos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cronos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.